Home Cart 0 Sign in  
X

[ CAS No. 126717-59-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 126717-59-7
Chemical Structure| 126717-59-7
Chemical Structure| 126717-59-7
Structure of 126717-59-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 126717-59-7 ]

Related Doc. of [ 126717-59-7 ]

Alternatived Products of [ 126717-59-7 ]

Product Details of [ 126717-59-7 ]

CAS No. :126717-59-7 MDL No. :MFCD03094943
Formula : C7H8BrNO Boiling Point : -
Linear Structure Formula :- InChI Key :VWNXCCTWVAQAPL-UHFFFAOYSA-N
M.W : 202.05 Pubchem ID :10798146
Synonyms :

Calculated chemistry of [ 126717-59-7 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.29
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.39
TPSA : 22.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.93 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.39
Log Po/w (XLOGP3) : 2.25
Log Po/w (WLOGP) : 2.16
Log Po/w (MLOGP) : 1.65
Log Po/w (SILICOS-IT) : 2.46
Consensus Log Po/w : 2.18

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.89
Solubility : 0.261 mg/ml ; 0.00129 mol/l
Class : Soluble
Log S (Ali) : -2.35
Solubility : 0.901 mg/ml ; 0.00446 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.4
Solubility : 0.081 mg/ml ; 0.000401 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.77

Safety of [ 126717-59-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 126717-59-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 126717-59-7 ]
  • Downstream synthetic route of [ 126717-59-7 ]

[ 126717-59-7 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 63071-03-4 ]
  • [ 126717-59-7 ]
YieldReaction ConditionsOperation in experiment
76%
Stage #1: With 1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione In tetrahydrofuran at 20℃; for 48 h; In the dark
Stage #2: With sodium thiosulfate In tetrahydrofuran; water for 1 h;
Step B.
3-Bromo-6-methoxy-2-methyl-pyridine.
A mixture of 2-methoxy-6-methyl-pyridine (15.2 g, 123 mmol) and 1,3-dibromo-5,5-dimethyl hydantoin (35.3 g, 123 mmol) in THF (1 L) was stirred at rt for 48 h in the dark.
The mixture was treated with 10percent aq. Na2S2O3 (100 mL) and stirred for 1 h.
The mixture was extracted with Et2O.
The organic layer was washed with H2O (2*), dried (MgSO4), and concentrated.
The residue was purified (SiO2; 0-5percent EtOAc/hexanes) to give the title compound (18.7 g, 76percent). MS (ESI): mass calcd. for C7H8BrNO, 200.98; m/z found, 202.2 [M+H]+. 1H NMR (CDCl3): 7.60 (d, J=8.6, 1H), 8.45 (d, J=8.7, 1H), 3.90 (s, 3H), 2.54 (s, 3H).
Reference: [1] Tetrahedron, 2000, vol. 56, # 20, p. 3181 - 3187
[2] Journal of the American Chemical Society, 2009, vol. 131, # 31, p. 11187 - 11194
[3] Synthetic Communications, 1997, vol. 27, # 1, p. 61 - 68
[4] Tetrahedron Letters, 1997, vol. 38, # 25, p. 4415 - 4416
[5] Journal of the Chemical Society - Perkin Transactions 1, 1998, # 19, p. 3151 - 3155
[6] Patent: US2006/287292, 2006, A1, . Location in patent: Page/Page column 28
[7] Patent: EP1847535, 2007, A1, . Location in patent: Page/Page column 123-124
[8] Patent: US2011/294857, 2011, A1,
[9] Science China Chemistry, 2012, vol. 55, # 6, p. 1097 - 1100
  • 2
  • [ 54923-31-8 ]
  • [ 74-88-4 ]
  • [ 126717-59-7 ]
YieldReaction ConditionsOperation in experiment
63%
Stage #1: With silver carbonate In chloroform at 20℃;
Stage #2: With triethylamine In chloroform for 1.5 h;
Example 3 3-(2,5-Dimethyl-6-oxo-1 6-dihydropyridin-3-(at)l)benzonitrile Step 1: 3-Bromo-6-methoxy-2-methylpyridine: A mixture of 5-bromo-6-methyl-1H-pyridin- 2-one (5.5 g, 29 mmol), silver carbonate (10.89 g, 39 mmol), iodomethane (13.6 mL, 217 mmol) and chloroform (115 mL) is stirred overnight in the dark at room temperature. Triethylamine (10 mL) is added and stirring continued for 1.5 hr. The reaction mixture is filtered through a pad of Hi-Flo and the filtrate is washed with water (100 mL), dried, filtered and concentrated. The residue is purified by filtration through a pad of silica gel washing with cyclohexane-20percent ethyl acetate. The solvent is concentrated to afford 3-bromo-6-methoxy-2- methylpyridine (3.7 g, 63percent yield) as an oil. LC/MS RT 3.76 min; MS m/e = 202/204 (M); NMR (CDCl3) 7.6 (1H, d), 6.43 (lH, d), 3.89 (3H, s), 2.57 (3H, s).
Reference: [1] Heterocycles, 1990, vol. 31, # 5, p. 819 - 824
[2] Patent: WO2005/97750, 2005, A1, . Location in patent: Page/Page column 71
  • 3
  • [ 124-41-4 ]
  • [ 39919-65-8 ]
  • [ 126717-59-7 ]
YieldReaction ConditionsOperation in experiment
96% at 65 - 75℃; for 6 h; A solution of 2,5-dibromo-6-picoline (30.6 kg, 122 mol, 1.00 eq) intoluene (154.2 kg) was dried by vacuum distillation at 40 °C 775 mmHg to remove 105.7 kg of distillate to produce a solution containing 40 ppm water. This was mixed with 25 weight percent sodium methoxide in methanol (124.1 kg, 574 mol, 4.71 eq) and the mixture was heated at 65-75 °C for 6 hours until reaction completion, (HPLC analysis indicated 1.6 area percent starting material remained). The mixture was cooled to 5 °C and water (98 L) was charged to the mixture followed by t-butylmethylether (97 kg). The layers were separated and the organic phase washed twice with 5percent brine (139 kg) and once with 20percent brine (165 kg). The organic phase was clarified by filtration and 51 kg was removed by vacuum distillation at 40 °C to produce a 2-methoxy-5-bromo-6-picoline solution (58.4 kg) of 40.6 wt percent purity (96percent yield). Part of this was purified by distillation for the purposes of recording the 13C NMR spectrum: 13C NMR (400 MHz, CDC13) 8 162.4, 154.4, 142.0, 111.8, 109.5, 53.6, 24.6.
Reference: [1] Patent: WO2005/51954, 2005, A2, . Location in patent: Page/Page column 39; 40
  • 4
  • [ 63071-03-4 ]
  • [ 126717-59-7 ]
Reference: [1] Dalton Transactions, 2014, vol. 43, # 15, p. 5667 - 5679
[2] Synthetic Communications, 1994, vol. 24, # 10, p. 1367 - 1379
  • 5
  • [ 63071-03-4 ]
  • [ 126717-59-7 ]
Reference: [1] Patent: US2003/125330, 2003, A1,
  • 6
  • [ 100848-70-2 ]
  • [ 126717-59-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2009, vol. 52, # 9, p. 3084 - 3092
  • 7
  • [ 3279-76-3 ]
  • [ 126717-59-7 ]
Reference: [1] Tetrahedron, 2000, vol. 56, # 20, p. 3181 - 3187
[2] Synthetic Communications, 1994, vol. 24, # 10, p. 1367 - 1379
[3] Synthetic Communications, 1994, vol. 24, # 10, p. 1367 - 1379
[4] Science China Chemistry, 2012, vol. 55, # 6, p. 1097 - 1100
  • 8
  • [ 63071-03-4 ]
  • [ 126717-59-7 ]
Reference: [1] Synthetic Communications, 1994, vol. 24, # 10, p. 1367 - 1379
  • 9
  • [ 1824-81-3 ]
  • [ 126717-59-7 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1998, # 19, p. 3151 - 3155
  • 10
  • [ 5315-25-3 ]
  • [ 126717-59-7 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1998, # 19, p. 3151 - 3155
  • 11
  • [ 126717-59-7 ]
  • [ 132606-40-7 ]
Reference: [1] Synthetic Communications, 1990, vol. 20, # 19, p. 2971 - 2977
  • 12
  • [ 126717-59-7 ]
  • [ 269058-49-3 ]
Reference: [1] Organic and Biomolecular Chemistry, 2003, vol. 1, # 16, p. 2865 - 2876
[2] Tetrahedron Letters, 2000, vol. 41, # 12, p. 2007 - 2009
[3] Patent: US2016/75711, 2016, A1,
  • 13
  • [ 126717-59-7 ]
  • [ 108-24-7 ]
  • [ 623942-84-7 ]
YieldReaction ConditionsOperation in experiment
1.75 g
Stage #1: With 3-chloro-benzenecarboperoxoic acid In chloroform at 0 - 20℃; for 24 h;
Stage #2: at 120℃; for 3 h;
Stage #3: With potassium carbonate In methanol; water at 20℃; for 1 h;
To a solution of 3-bromo-6-methoxy-2-methylpyridine (CAS No. 126717-59-7) (5.5 g, 27.2 mmol, 1 equivalent) in chloroform (100 mL) was added 65percent mCPBA (10.8 g, 40.8 mmol, 1.5 equivalents) at 0° C.
The reaction mixture was warmed up to room temperature and stirred for 24 hours.
To the reaction mixture were added an aqueous sodium thiosulfate pentahydrate solution and a saturated aqueous sodium hydrogen carbonate solution, and the mixture was extracted with chloroform.
The resulting organic layer was dried over magnesium sulfate, filtered, and then concentrated under reduced pressure.
The residue was purified with silica gel column chromatography (silica gel, 0percent-20percent methanol/ethyl acetate).
The resulting compound was stirred in acetic anhydride (20 mL) at 120° C. for 3 hours.
To the reaction mixture was added methanol, and the mixture was concentrated under reduced pressure.
To the residue was added water, and the mixture was extracted with ethyl acetate.
The combined organic layers were washed with a saturated aqueous sodium chloride solution.
The organic layers were dried over magnesium sulfate, filtered, and then concentrated under reduced pressure.
The resulting residue was purified with silica gel column chromatography (silica gel, 20percent-75percent ethyl acetate/n-heptane).
To the resulting compound in methanol (22 mL) was added potassium carbonate (1 M aqueous solution, 10.4 mL) at room temperature.
After stirring at the same temperature for 1 hour, the reaction mixture was concentrated under reduced pressure.
To the residue was added water, and the mixture was extracted with chloroform.
The combined organic layers were washed with a saturated aqueous sodium chloride solution.
The organic layers were dried over magnesium sulfate, filtered, and then concentrated under reduced pressure to afford the title compound (1.75 g).
1H-NMR (400 MHz, CDCl3) δ (ppm): 3.97 (s, 3H), 4.03 (t, J=4.7 Hz, 1H), 4.68 (dd, J=4.7, 0.8 Hz, 2H), 6.57-6.64 (m, 1H), 7.69 (d, J=8.6 Hz, 1H).
Reference: [1] Patent: US2017/137436, 2017, A1, . Location in patent: Paragraph 0203-0205
  • 14
  • [ 126717-59-7 ]
  • [ 623942-84-7 ]
Reference: [1] Organic and Biomolecular Chemistry, 2003, vol. 1, # 16, p. 2865 - 2876
[2] Tetrahedron Letters, 2000, vol. 41, # 12, p. 2007 - 2009
[3] Patent: US2016/75711, 2016, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 126717-59-7 ]

Bromides

Chemical Structure| 819069-57-3

[ 819069-57-3 ]

3-Bromo-6-methoxy-2,4-dimethylpyridine

Similarity: 0.94

Chemical Structure| 623942-84-7

[ 623942-84-7 ]

(3-Bromo-6-methoxypyridin-2-yl)methanol

Similarity: 0.91

Chemical Structure| 1186637-43-3

[ 1186637-43-3 ]

3-Bromo-6-methoxypicolinonitrile

Similarity: 0.89

Chemical Structure| 156094-63-2

[ 156094-63-2 ]

2-(Bromomethyl)-6-methoxypyridine

Similarity: 0.86

Chemical Structure| 55849-30-4

[ 55849-30-4 ]

5-Bromo-2-ethoxypyridine

Similarity: 0.82

Ethers

Chemical Structure| 819069-57-3

[ 819069-57-3 ]

3-Bromo-6-methoxy-2,4-dimethylpyridine

Similarity: 0.94

Chemical Structure| 623942-84-7

[ 623942-84-7 ]

(3-Bromo-6-methoxypyridin-2-yl)methanol

Similarity: 0.91

Chemical Structure| 1186637-43-3

[ 1186637-43-3 ]

3-Bromo-6-methoxypicolinonitrile

Similarity: 0.89

Chemical Structure| 156094-63-2

[ 156094-63-2 ]

2-(Bromomethyl)-6-methoxypyridine

Similarity: 0.86

Chemical Structure| 55849-30-4

[ 55849-30-4 ]

5-Bromo-2-ethoxypyridine

Similarity: 0.82

Related Parent Nucleus of
[ 126717-59-7 ]

Pyridines

Chemical Structure| 819069-57-3

[ 819069-57-3 ]

3-Bromo-6-methoxy-2,4-dimethylpyridine

Similarity: 0.94

Chemical Structure| 623942-84-7

[ 623942-84-7 ]

(3-Bromo-6-methoxypyridin-2-yl)methanol

Similarity: 0.91

Chemical Structure| 1186637-43-3

[ 1186637-43-3 ]

3-Bromo-6-methoxypicolinonitrile

Similarity: 0.89

Chemical Structure| 156094-63-2

[ 156094-63-2 ]

2-(Bromomethyl)-6-methoxypyridine

Similarity: 0.86

Chemical Structure| 55849-30-4

[ 55849-30-4 ]

5-Bromo-2-ethoxypyridine

Similarity: 0.82